Furthermore, the Deventer-Alkmaar HF (DEAL-HF) study that followed patients with chronic HF for up to 6.5 years, demonstrated that blood Gal-3 levels were a significant predictor of mortality even after adjusting for age, sex and the known risk factors [11]. The gene discussed is LGALS3; the disease is hydrops fetalis.